Vascular Endothelial Growth Factor in the Circulation in Cancer Patients May Not Be a Relevant Biomarker

BACKGROUND: Levels of circulating vascular endothelial growth factor (VEGF) have widely been used as biomarker for angiogenic activity in cancer. For this purpose, non-standardized measurements in plasma and serum were used, without correction for artificial VEGF release by platelets activated ex vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Niers, Tatjana M. H., Richel, Dick J., Meijers, Joost C. M., Schlingemann, Reinier O.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102663/
https://www.ncbi.nlm.nih.gov/pubmed/21637343
http://dx.doi.org/10.1371/journal.pone.0019873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102663/
https://www.ncbi.nlm.nih.gov/pubmed/21637343
http://dx.doi.org/10.1371/journal.pone.0019873

Ejemplares similares